Roche Diagnostics India looks at 15 per cent IVD market share in 2 years Ruby Khatun Khatun4 Sept 2017 10:30 AM ISTNew Delhi: Roche Diagnostics India is aiming at 15 per cent share of the in-vitro diagnostics market in the next two years as part of its growth plans...
Jubilant Pharma completes US radio-pharmacy Triad Isotopes acquisition Ruby Khatun Khatun4 Sept 2017 10:00 AM ISTNew Delhi: Jubilant Life Sciences said its subsidiary Jubilant Pharma has completed the acquisition of the US radiopharmacy business of Triad Isotopes...
1mg acquires Dawailelo to strengthen pharmacy operations Ruby Khatun Khatun4 Sept 2017 9:30 AM ISTNew Delhi: 1mg, India’s largest digital health platform, has announced that it has acquired Dawailelo.com, a technology-based facilitator in the...
Nestle shuts Swiss skin health products factory Ruby Khatun Khatun4 Sept 2017 9:15 AM ISTZURICH: Nestle said on Thursday it was closing a Swiss factory which makes products for its skin health business, responding to a slowdown in a...
Abbott releases new round of cyber updates for St. Jude pacemakers Ruby Khatun Khatun3 Sept 2017 1:37 PM ISTNEW YORK: Abbott Laboratories said on Tuesday it would issue updates to reduce the risk of its St. Jude heart implants being hacked and to warn...
Health-tech startup Mfine raises Rs 9.58 crore from Stellaris Venture Partners Ruby Khatun Khatun3 Sept 2017 10:00 AM ISTHyderabad: Mfine, India’s first AI-driven healthcare network, founded by former Myntra executives Prasad Kompalli and Ashutosh Lawania, has raised...
Fitbit launches Ionic, the ultimate health and fitness smartwatch Ruby Khatun Khatun3 Sept 2017 9:49 AM ISTSAN FRANCISCO: Fitbit, the leading global wearables brand, announced its first smartwatch – Fitbit Ionic™. A health and fitness first platform, Ionic...
Daiichi Sankyo denies 2016 takeover bid by AstraZeneca Ruby Khatun Khatun3 Sept 2017 9:45 AM ISTTOKYO: Japanese drugmaker Daiichi Sankyo denied on Thursday it received a takeover bid last year from Britain’s AstraZeneca, following speculation...
Bristol-Myers, Daiichi Sankyo to test Opdivo combo for cancers Ruby Khatun Khatun3 Sept 2017 9:30 AM ISTBristol-Myers Squibb Co and Daiichi Sankyo said they were evaluating a combination of Bristol-Myers’ immuno-oncology drug, Opdivo, with the Japanese...
475,000 dollar cancer drug- Novartis draws fire, justifies fire Ruby Khatun Khatun2 Sept 2017 10:50 AM ISTZURICH: Novartis’s new gene-modifying cancer therapy’s $475,000-per-patient sticker price has drawn fire from advocate groups calling for cheaper...
Lupin launches Lanthanum Carbonate chewable tablets in US Ruby Khatun Khatun2 Sept 2017 10:33 AM ISTNew Delhi: Drug firm Lupin on Thursday said it has launched generic Lanthanum Carbonate chewable tablets used for reducing serum phosphate in patients...
Ajanta Pharma launches pain relief tablets in US Ruby Khatun Khatun2 Sept 2017 10:33 AM ISTNew Delhi: Ajanta Pharma on Thursday announced launch of eletriptan hydrobromide tablets, used to treat headaches, in the US market."It is a...
